Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Key Market Segments
1.2.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
1.2.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Landscape
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Manufacturers (2017-2022)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share by Manufacturers (2017-2022)
3.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Sites, Area Served, Product Type
3.6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Competitive Situation and Trends
3.6.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Chain Analysis
4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Market Share by Type (2017-2022)
6.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Type (2017-2022)

7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Sales by Application (2017-2022)
7.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) by Application (2017-2022)
7.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Application (2017-2022)

8 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segmentation by Region
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
8.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
8.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Bausch Health
9.1.1 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.1.2 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.1.4 Bausch Health Business Overview
9.1.5 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis
9.1.6 Bausch Health Recent Developments
9.2 Allergan
9.2.1 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.2.2 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Sebela Pharmaceuticals
9.3.1 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.3.2 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.3.4 Sebela Pharmaceuticals Business Overview
9.3.5 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis
9.3.6 Sebela Pharmaceuticals Recent Developments
9.4 Astellas Pharmaceuticals
9.4.1 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.4.2 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.4.4 Astellas Pharmaceuticals Business Overview
9.4.5 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis
9.4.6 Astellas Pharmaceuticals Recent Developments
9.5 Amneal Pharms
9.5.1 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.5.2 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.5.4 Amneal Pharms Business Overview
9.5.5 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis
9.5.6 Amneal Pharms Recent Developments
9.6 Pharscin Pharma
9.6.1 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information
9.6.2 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview
9.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Market Performance
9.6.4 Pharscin Pharma Business Overview
9.6.5 Pharscin Pharma Recent Developments
10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Region
10.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast
10.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region
10.2.4 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Country

11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2022-2028)
11.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2022-2028)
11.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by Application (2022-2028)
11.2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Application
11.2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) Forecast by Application (2022-2028)

12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs as of 2021)

Table 10. Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Sites and Area Served

Table 12. Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type

Table 13. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Challenges

Table 22. Market Restraints

Table 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Type (K Units)

Table 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Type (M USD)

Table 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Type (2017-2022)

Table 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Type (2017-2022)

Table 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) by Type (2017-2022)

Table 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Share by Type (2017-2022)

Table 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit) by Type (2017-2022)

Table 30. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) by Application

Table 31. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Application

Table 32. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2017-2022) & (K Units)

Table 33. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2017-2022)

Table 34. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Application (2017-2022) & (M USD)

Table 35. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2017-2022)

Table 36. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Application (2017-2022)

Table 37. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022) & (K Units)

Table 38. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2017-2022)

Table 39. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)

Table 40. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022) & (K Units)

Table 42. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Region (2017-2022) & (K Units)

Table 44. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 45. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 46. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Bausch Health Business Overview

Table 48. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis

Table 49. Bausch Health Recent Developments

Table 50. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 51. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 52. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Allergan Business Overview

Table 54. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis

Table 55. Allergan Recent Developments

Table 56. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 57. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 58. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Sebela Pharmaceuticals Business Overview

Table 60. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis

Table 61. Sebela Pharmaceuticals Recent Developments

Table 62. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 63. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 64. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Astellas Pharmaceuticals Business Overview

Table 66. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis

Table 67. Astellas Pharmaceuticals Recent Developments

Table 68. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 69. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 70. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Amneal Pharms Business Overview

Table 72. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs SWOT Analysis

Table 73. Amneal Pharms Recent Developments

Table 74. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Basic Information

Table 75. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Overview

Table 76. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Pharscin Pharma Business Overview

Table 78. Pharscin Pharma Recent Developments

Table 79. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (K Units)

Table 80. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region (M USD)

Table 81. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 82. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 83. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 84. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 85. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Region (2022-2028) & (K Units)

Table 86. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Region (2022-2028) & (M USD)

Table 87. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 88. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 89. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Country (2022-2028) & (Units)

Table 90. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 91. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Type (2022-2028) & (K Units)

Table 92. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Type (2022-2028) & (M USD)

Table 93. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price Forecast by Type (2022-2028) & (USD/Unit)

Table 94. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) Forecast by Application (2022-2028)

Table 95. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD), 2017-2028

Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) (2017-2028)

Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size (M USD) by Country (M USD)

Figure 11. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Manufacturers in 2020

Figure 12. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Manufacturers in 2020

Figure 13. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Type

Figure 18. Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2017-2022)

Figure 19. Sales Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2021

Figure 20. Market Size Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type (2017-2022)

Figure 21. Market Size Market Share of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application

Figure 24. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application (2017-2022)

Figure 25. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Application in 2021

Figure 26. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application (2017-2022)

Figure 27. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share by Application in 2020

Figure 28. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Growth Rate by Application (2017-2022)

Figure 29. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region (2017-2022)

Figure 30. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020

Figure 32. U.S. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020

Figure 37. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2020

Figure 44. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K

Units)

Figure 47. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (K Units)

Figure 50. South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Country in 2020

Figure 51. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Type (2022-2028)

Figure 65. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Forecast by Application (2022-2028)

Figure 66. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share Forecast by Application (2022-2028)